Marketing & Digital Operations Intern at Delcath Systems, Inc. | USA | $20/hr – $25/hr

Delcath Systems, Inc.

Marketing & Digital Operations Intern

USA (Remote)

$20/hr – $25/hrIntern/New GradInternship

Posted 3 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the hands-on support for digital operations and intranet/content management at Delcath, focusing on SharePoint expansion, website and content QA, and marketing workflows.

Own execution of intranet expansion and content migration tasks with cross-functional visibility.
Must-have: Strong organizational skills and attention to data accuracy.
Standout: Exposure to enterprise digital platforms, analytics, and CMS workflows.

Job Description

Responsibilities

Support expansion of SharePoint intranet pages across departments
Assist with structured content migration from legacy systems (VPN) to SharePoint
Ensure content is organized, accurate, and aligned to governance standards
Help maintain project tracking tools
Assist in updates and QA for Delcath’s web properties (Delcath.com and related sites)
Support SEO implementation efforts (metadata, content structure, search performance tracking)
Help implement and test UX improvements across web and intranet experiences
Support HubSpot initiatives including email builds and testing
Assist with execution of marketing communications workflows
Help evaluate tools like Showpad for sales enablement and content distribution

Requirements

Pursuing a degree in Marketing, Digital Media, Information Systems, User Experience, or a related field
Strong organizational and problem-solving skills
Interest in digital marketing, UX, or data analytics
Strong attention to detail, especially in content and data accuracy
Ability to manage multiple projects and communicate clearly across teams
Comfortable working within structured processes and following detailed checklists

Preferred

Comfortable working in tools like Wordpress, GA4, MS Office Suite; familiarity with CMS or CRM platforms is a plus

Delcath Systems, Inc.

Delcath Systems, Inc. (NASDAQ- DCTH) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. Our proprietary product---Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. Delcath is in late-stage clinical development in the United States with initial commercial activities in Europe, where the Melphalan/HDS is marketed as a CE Marked device under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT). Our commercial strategy for CHEMOSAT is to steadily grow clinical adoption in major European markets and utilize physician experience to support appeals for reimbursement. Since launch over 250 CHEMOSAT treatments have been performed at over 20 leading European cancer centers. In 2016, we launched our FOCUS Pivotal Study in Hepatic Dominant Ocular Melanoma, and are investigating orphan indications in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. We believe Melphalan/HDS is uniquely positioned to treat the entire liver as a stand-alone or complementary therapy.

Founded in 1987

New York, New York, USA

135 employees (4 in marketing)

www.delcath.com